×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Contact Us
About Us
Subscribe
My Portfolio
My Account
Contact Us
About Us
Subscribe
My Account
My Portfolio
Logo

Insider Transactions by BVF PARTNERS L P/IL

Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
XOMAXOMA Royalty CorpBVF PARTNERS L P/IL10% OwnerJan 24, 2025Sale$26.10149,9753,914,3480Jan 28, 2025, 05:23 PM
XOMAXOMA Royalty CorpBVF PARTNERS L P/IL10% OwnerJan 24, 2025Sale$26.10500,74213,069,3661,532,861Jan 28, 2025, 05:23 PM
THRDThird Harmonic Bio, Inc.BVF PARTNERS L P/ILSee Explanation of ResponsesOct 29, 2024Sale$14.301,000,00014,300,0001,794,218Oct 31, 2024, 05:53 PM
MLTXMoonLake ImmunotherapeuticsBVF PARTNERS L P/ILDirectorOct 04, 2024Sale$50.002,000,000100,003,19710,235,089Oct 08, 2024, 06:50 PM
PNTPOINT Biopharma Global Inc.BVF PARTNERS L P/ILFormer 10% OwnerDec 18, 2023Sale$12.4517,161,278213,657,9080Dec 20, 2023, 06:09 PM
RPTXRepare Therapeutics Inc.BVF PARTNERS L P/IL10% OwnerNov 16, 2023Buy$5.38295,7451,592,2025,309,432Nov 17, 2023, 04:54 PM
RPTXRepare Therapeutics Inc.BVF PARTNERS L P/IL10% OwnerNov 15, 2023Buy$5.00931,5564,657,6875,155,739Nov 17, 2023, 04:54 PM
KYMRKymera Therapeutics, Inc.BVF PARTNERS L P/ILDirectorNov 02, 2023Buy$11.64216,4062,519,9182,552,306Nov 06, 2023, 06:07 PM
KYMRKymera Therapeutics, Inc.BVF PARTNERS L P/ILDirectorNov 03, 2023Buy$14.07197,6992,781,4072,656,191Nov 06, 2023, 06:07 PM
RPTXRepare Therapeutics Inc.BVF PARTNERS L P/IL10% OwnerNov 02, 2023Buy$3.60783,7092,821,3524,662,402Nov 03, 2023, 05:37 PM
OLMAOlema Pharmaceuticals, Inc.BVF PARTNERS L P/ILDirectorSep 12, 2023Buy$9.841,505,93214,818,3714,688,954Sep 14, 2023, 04:25 PM
CTICCTI BIOPHARMA CORPBVF PARTNERS L P/ILDirectorJun 26, 2023Option Exercise$9.101,569,28614,280,5030Jun 28, 2023, 06:26 PM
CTICCTI BIOPHARMA CORPBVF PARTNERS L P/ILDirectorJun 26, 2023Option Exercise$9.107,286,87466,310,5560Jun 28, 2023, 06:26 PM
KYMRKymera Therapeutics, Inc.BVF PARTNERS L P/ILDirectorJan 11, 2023Buy$29.8922,110660,7992,491,703Jan 13, 2023, 05:08 PM
KYMRKymera Therapeutics, Inc.BVF PARTNERS L P/ILDirectorJan 12, 2023Buy$31.2418,897590,3912,494,688Jan 13, 2023, 05:08 PM
XOMAXOMA CorpBVF PARTNERS L P/ILDirectorJan 05, 2023Buy$18.3919,000349,3191,788,168Jan 09, 2023, 05:44 PM
XOMAXOMA CorpBVF PARTNERS L P/ILDirectorJan 06, 2023Buy$21.983,24971,4191,789,844Jan 09, 2023, 05:44 PM
THRDThird Harmonic Bio, Inc.BVF PARTNERS L P/IL10% OwnerDec 20, 2022Buy$4.11214,063879,4992,332,638Dec 22, 2022, 06:49 PM
RAINRain Therapeutics Inc.BVF PARTNERS L P/ILDirectorNov 08, 2022Buy$5.831,710,3589,971,3872,870,985Nov 10, 2022, 06:31 PM
XOMAXOMA CorpBVF PARTNERS L P/ILDirectorSep 23, 2022Buy$16.5016,600273,8501,780,495Sep 27, 2022, 07:22 PM
XOMAXOMA CorpBVF PARTNERS L P/ILDirectorSep 26, 2022Buy$16.836,360107,0501,783,834Sep 27, 2022, 07:22 PM
XOMAXOMA CorpBVF PARTNERS L P/ILDirectorSep 27, 2022Buy$16.891,68228,4091,784,838Sep 27, 2022, 07:22 PM
XOMAXOMA CorpBVF PARTNERS L P/ILDirectorSep 14, 2022Buy$17.2526,441456,0441,571,338Sep 16, 2022, 06:30 PM
XOMAXOMA CorpBVF PARTNERS L P/ILDirectorSep 15, 2022Buy$17.965,575100,1381,576,913Sep 16, 2022, 06:30 PM
XOMAXOMA CorpBVF PARTNERS L P/ILDirectorSep 16, 2022Buy$17.8924,293434,5361,773,780Sep 16, 2022, 06:30 PM
KYMRKymera Therapeutics, Inc.BVF PARTNERS L P/ILDirectorAug 22, 2022Buy$26.00545,52514,183,6502,480,742Aug 23, 2022, 05:35 PM
CTICCTI BIOPHARMA CORPBVF PARTNERS L P/ILDirectorAug 09, 2022Sale$6.127,210,56644,128,663235,130Aug 11, 2022, 05:52 PM
CTICCTI BIOPHARMA CORPBVF PARTNERS L P/ILDirectorAug 09, 2022Sale$6.121,289,4347,891,3366,148Aug 11, 2022, 05:52 PM
RPTXRepare Therapeutics Inc.BVF PARTNERS L P/IL10% OwnerJun 13, 2022Buy$12.73149,1611,898,8194,443,423Jun 15, 2022, 06:15 PM
OLMAOlema Pharmaceuticals, Inc.BVF PARTNERS L P/ILDirectorJun 10, 2022Buy$4.03200,000806,9003,913,676Jun 14, 2022, 04:46 PM
RPTXRepare Therapeutics Inc.BVF PARTNERS L P/IL10% OwnerJun 02, 2022Buy$11.681,186,04513,855,8524,011,604Jun 06, 2022, 06:14 PM
RPTXRepare Therapeutics Inc.BVF PARTNERS L P/IL10% OwnerJun 03, 2022Buy$12.29644,0447,912,7254,364,948Jun 06, 2022, 06:14 PM
RPTXRepare Therapeutics Inc.BVF PARTNERS L P/IL10% OwnerJun 06, 2022Buy$13.216,86990,7524,368,757Jun 06, 2022, 06:14 PM
CGEMCullinan Oncology, Inc.BVF PARTNERS L P/IL10% OwnerJun 01, 2022Buy$11.00751,3968,264,9054,058,854Jun 03, 2022, 06:24 PM
KYMRKymera Therapeutics, Inc.BVF PARTNERS L P/ILDirectorMay 26, 2022Buy$14.21224,0573,183,9842,159,903May 31, 2022, 07:50 PM
KYMRKymera Therapeutics, Inc.BVF PARTNERS L P/ILDirectorMay 27, 2022Buy$14.7865,369966,3372,195,696May 31, 2022, 07:50 PM
KYMRKymera Therapeutics, Inc.BVF PARTNERS L P/ILDirectorMay 20, 2022Buy$14.0010,100141,3942,036,860May 24, 2022, 08:09 PM
RPTXRepare Therapeutics Inc.BVF PARTNERS L P/IL10% OwnerMay 18, 2022Buy$8.50420,0003,570,0003,350,950May 20, 2022, 06:09 PM
CGEMCullinan Oncology, Inc.BVF PARTNERS L P/IL10% OwnerMay 12, 2022Buy$9.061,000,0009,060,0003,599,615May 16, 2022, 07:34 PM
CGEMCullinan Oncology, Inc.BVF PARTNERS L P/IL10% OwnerMay 13, 2022Buy$9.14109,9001,003,9373,653,213May 16, 2022, 07:34 PM
KYMRKymera Therapeutics, Inc.BVF PARTNERS L P/ILDirectorMay 05, 2022Buy$19.60150,0002,939,8651,975,767May 09, 2022, 07:20 PM
KYMRKymera Therapeutics, Inc.BVF PARTNERS L P/ILDirectorMay 06, 2022Buy$19.25100,0001,925,5002,030,977May 09, 2022, 07:20 PM
CGEMCullinan Oncology, Inc.BVF PARTNERS L P/IL10% OwnerApr 01, 2022Buy$10.75276,0002,966,9723,056,616Apr 05, 2022, 06:45 PM
KYMRKymera Therapeutics, Inc.BVF PARTNERS L P/ILDirectorJan 27, 2022Buy$38.3395,9013,676,0681,880,187Jan 31, 2022, 07:44 PM
KYMRKymera Therapeutics, Inc.BVF PARTNERS L P/ILDirectorJan 31, 2022Buy$40.7034,4081,400,4061,900,272Jan 31, 2022, 07:44 PM
KYMRKymera Therapeutics, Inc.BVF PARTNERS L P/ILDirectorJan 24, 2022Buy$37.76272,76710,300,6371,822,145Jan 26, 2022, 07:43 PM
RPTXRepare Therapeutics Inc.BVF PARTNERS L P/IL10% OwnerJan 19, 2022Buy$14.10997,96114,071,2503,126,562Jan 21, 2022, 05:12 PM
RAINRain Therapeutics Inc.BVF PARTNERS L P/ILDirectorJan 07, 2022Buy$12.00496,3855,956,6201,734,960Jan 10, 2022, 06:03 PM
RAINRain Therapeutics Inc.BVF PARTNERS L P/ILDirectorJan 06, 2022Buy$12.0061,343736,0181,141,759Jan 10, 2022, 06:03 PM
OLMAOlema Pharmaceuticals, Inc.BVF PARTNERS L P/ILDirectorNov 30, 2021Buy$9.39739,6756,945,7703,755,093Dec 02, 2021, 08:45 PM
MRUSMerus N.V.BVF PARTNERS L P/IL10% OwnerOct 07, 2021Sale$27.53985,44727,130,4392,165,675Oct 08, 2021, 09:24 PM
MRUSMerus N.V.BVF PARTNERS L P/IL10% OwnerOct 08, 2021Sale$27.79147,2674,092,0352,085,664Oct 08, 2021, 09:24 PM
RAINRain Therapeutics Inc.BVF PARTNERS L P/ILDirectorSep 21, 2021Buy$13.9411,033153,8291,479,460Sep 23, 2021, 08:05 PM
RAINRain Therapeutics Inc.BVF PARTNERS L P/ILDirectorSep 13, 2021Buy$16.49392,2696,468,5161,473,119Sep 15, 2021, 05:23 PM
MRUSMerus N.V.BVF PARTNERS L P/IL10% OwnerJul 02, 2021Sale$20.752,186,02245,359,9572,696,674Jul 07, 2021, 04:49 PM
RAINRain Therapeutics Inc.BVF PARTNERS L P/ILDirectorJul 01, 2021Buy$15.65317,2794,965,4161,113,757Jul 06, 2021, 07:34 PM
RAINRain Therapeutics Inc.BVF PARTNERS L P/ILDirectorJul 06, 2021Buy$15.25269,7234,113,2761,259,873Jul 06, 2021, 07:34 PM
KYMRKymera Therapeutics, Inc.BVF PARTNERS L P/ILDirectorJul 01, 2021Buy$47.00544,16625,575,8021,664,104Jul 06, 2021, 06:40 PM
RAINRain Therapeutics Inc.BVF PARTNERS L P/ILDirectorMay 24, 2021Buy$15.901,36121,633941,300May 25, 2021, 08:31 PM
RAINRain Therapeutics Inc.BVF PARTNERS L P/ILDirectorMay 21, 2021Buy$15.94121,9861,944,701940,581May 25, 2021, 08:31 PM
RAINRain Therapeutics Inc.BVF PARTNERS L P/ILDirectorMay 18, 2021Buy$16.65191,1973,183,430865,148May 20, 2021, 07:18 PM
RAINRain Therapeutics Inc.BVF PARTNERS L P/ILDirectorMay 19, 2021Buy$15.8817,268274,290874,339May 20, 2021, 07:18 PM
RAINRain Therapeutics Inc.BVF PARTNERS L P/ILDirectorApr 23, 2021Option Exercise$16.901,105,89618,694,901714,942Apr 27, 2021, 08:41 PM
RAINRain Therapeutics Inc.BVF PARTNERS L P/ILDirectorApr 26, 2021Option Exercise$14.9027,413408,478729,732Apr 27, 2021, 08:41 PM
CTICCTI BIOPHARMA CORPBVF PARTNERS L P/ILDirectorApr 01, 2021Buy$2.502,000,0005,000,0004,085,933Apr 05, 2021, 08:15 PM
MRUSMerus N.V.BVF PARTNERS L P/IL10% OwnerMar 30, 2021Buy$19.75300,0005,925,0003,803,152Apr 01, 2021, 05:18 PM
MRUSMerus N.V.BVF PARTNERS L P/IL10% OwnerMar 22, 2021Buy$22.7579,5001,808,6253,638,152Mar 24, 2021, 05:15 PM
MRUSMerus N.V.BVF PARTNERS L P/IL10% OwnerMar 16, 2021Buy$23.00250,0005,749,9003,566,396Mar 18, 2021, 06:07 PM
INFIINFINITY PHARMACEUTICALS, INC.BVF PARTNERS L P/IL10% OwnerFeb 11, 2021Sale$5.372,260,08512,133,4924,448,421Feb 16, 2021, 04:35 PM
IDYAIDEAYA Biosciences, Inc.BVF PARTNERS L P/ILSee Explanation of ResponsesFeb 02, 2021Sale$18.0046,409835,3621,642,186Feb 04, 2021, 05:15 PM
INFIINFINITY PHARMACEUTICALS, INC.BVF PARTNERS L P/IL10% OwnerJan 22, 2021Sale$4.145,848,52024,205,8555,663,912Jan 26, 2021, 05:27 PM
MRUSMerus N.V.BVF PARTNERS L P/IL10% OwnerJan 21, 2021Buy$24.75844,68020,905,8303,513,335Jan 25, 2021, 06:51 PM
MRUSMerus N.V.BVF PARTNERS L P/IL10% OwnerDec 18, 2020Buy$16.05160,0002,568,0003,055,521Dec 22, 2020, 07:04 PM
XOMAXOMA CorpBVF PARTNERS L P/ILDirectorDec 11, 2020Buy$25.00200,0005,000,000200,000Dec 15, 2020, 07:09 PM
CYTKCYTOKINETICS INCBVF PARTNERS L P/ILSee Explanaton of ResponsesDec 09, 2020Sale$18.00430,9547,757,1723,811,271Dec 11, 2020, 06:48 PM
OLMAOlema Pharmaceuticals, Inc.BVF PARTNERS L P/ILDirectorNov 19, 2020Buy$19.001,135,33421,571,3463,392,663Nov 20, 2020, 08:02 PM
FPRXFIVE PRIME THERAPEUTICS, INC.BVF PARTNERS L P/ILSee Explanaton of ResponsesNov 11, 2020Sale$20.197,393,340149,247,143670,695Nov 13, 2020, 05:29 PM
GLYCGLYCOMIMETICS INCBVF PARTNERS L P/IL10% OwnerNov 04, 2020Buy$2.601,266,7373,293,5164,980,812Nov 06, 2020, 06:33 PM
FPRXFIVE PRIME THERAPEUTICS, INC.BVF PARTNERS L P/IL10% OwnerNov 04, 2020Buy$4.88416,5622,034,5724,594,679Nov 06, 2020, 06:30 PM
FPRXFIVE PRIME THERAPEUTICS, INC.BVF PARTNERS L P/IL10% OwnerNov 06, 2020Buy$4.9830,000149,5204,611,909Nov 06, 2020, 06:30 PM
GLYCGLYCOMIMETICS INCBVF PARTNERS L P/IL10% OwnerOct 30, 2020Buy$2.75932,6122,564,6834,306,320Nov 03, 2020, 04:44 PM
FPRXFIVE PRIME THERAPEUTICS, INC.BVF PARTNERS L P/IL10% OwnerOct 06, 2020Buy$5.03345,2411,738,2884,336,875Oct 08, 2020, 05:27 PM
FPRXFIVE PRIME THERAPEUTICS, INC.BVF PARTNERS L P/IL10% OwnerSep 22, 2020Buy$3.8032122541,116Sep 24, 2020, 07:49 PM
XOMAXOMA CorpBVF PARTNERS L P/ILDirectorSep 21, 2020Buy$18.3922,328410,5022,023,276Sep 23, 2020, 07:26 PM
XOMAXOMA CorpBVF PARTNERS L P/ILDirectorSep 22, 2020Buy$18.4511,951220,4452,030,236Sep 23, 2020, 07:26 PM
XOMAXOMA CorpBVF PARTNERS L P/ILDirectorSep 23, 2020Buy$18.2017,089311,0162,040,124Sep 23, 2020, 07:26 PM
MRUSMerus N.V.BVF PARTNERS L P/IL10% OwnerSep 15, 2020Buy$11.75146,7541,724,3602,940,553Sep 17, 2020, 07:42 PM
MRUSMerus N.V.BVF PARTNERS L P/IL10% OwnerSep 10, 2020Buy$11.10189,6512,104,7852,862,802Sep 14, 2020, 08:14 PM
XOMAXOMA CorpBVF PARTNERS L P/ILDirectorSep 04, 2020Buy$18.777,737145,2282,011,017Sep 10, 2020, 08:10 AM
MRUSMerus N.V.BVF PARTNERS L P/IL10% OwnerSep 03, 2020Buy$11.17201,9062,255,2902,762,341Sep 08, 2020, 07:08 PM
XOMAXOMA CorpBVF PARTNERS L P/ILDirectorAug 28, 2020Buy$19.172,04439,1871,988,067Sep 01, 2020, 08:37 PM
XOMAXOMA CorpBVF PARTNERS L P/ILDirectorAug 31, 2020Buy$18.4816,005295,7821,997,210Sep 01, 2020, 08:37 PM
XOMAXOMA CorpBVF PARTNERS L P/ILDirectorSep 01, 2020Buy$18.8717,572331,5152,007,110Sep 01, 2020, 08:37 PM
XOMAXOMA CorpBVF PARTNERS L P/ILDirectorAug 21, 2020Buy$19.3210,805208,7701,976,998Aug 25, 2020, 08:10 PM
XOMAXOMA CorpBVF PARTNERS L P/ILDirectorAug 24, 2020Buy$19.3111,683225,5911,983,502Aug 25, 2020, 08:10 PM
XOMAXOMA CorpBVF PARTNERS L P/ILDirectorAug 25, 2020Buy$19.755,687112,2901,986,945Aug 25, 2020, 08:10 PM
KYMRKymera Therapeutics, Inc.BVF PARTNERS L P/ILDirectorAug 21, 2020Option Exercise$20.00978,69319,573,8601,359,109Aug 25, 2020, 06:48 PM
XOMAXOMA CorpBVF PARTNERS L P/IL10% OwnerAug 18, 2020Buy$19.2789517,2461,962,532Aug 20, 2020, 06:56 PM
XOMAXOMA CorpBVF PARTNERS L P/IL10% OwnerAug 19, 2020Buy$19.703,49668,8771,966,028Aug 20, 2020, 06:56 PM
XOMAXOMA CorpBVF PARTNERS L P/IL10% OwnerAug 20, 2020Buy$19.121,77233,8811,967,800Aug 20, 2020, 06:56 PM

Looking for more premium content?

We have created a comprehensive group of tools that allows you to estimate the intrinsic value of investments.

Subscribe